Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney S Graham

Showing results (101-110 of 420) with videos related to

Pageof 42
Sort By:
Journal of the International AIDS Society|December 29, 2017
Recent progress in immune-based interventions to prevent HIV-1 transmission to childrenYegor Voronin, Ilesh Jani, Barney S Graham, et al.
ACS Biomaterials Science & Engineering|January 26, 2018
Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell ResponsesBenjamin Schwarz, Kaitlyn M Morabito, Tracy J Ruckwardt, et al.
Plos Pathogens|March 5, 2016
A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited ImmunopathologyJie Liu, Elias K Haddad, Joshua Marceau, et al.
Msphere|April 26, 2019
Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus ProteinsRutger M Schepp, Cornelis A M de Haan, Deidre Wilkins, et al.
Plos One|February 12, 2020
Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidatesXueqiao Liu, Bo Liang, Xiang Liu, et al.
Nature Communications|March 18, 2023
Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F proteinPatrick O Byrne, Brian E Fisher, David R Ambrozak, et al.
Plos One|November 5, 2010
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)Laurence Peiperl, Cecilia Morgan, Zoe Moodie, et al.
Virology|June 5, 2019
A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virusYouri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Molecular Immunology|March 10, 2022
Functional reconstitution of the MERS CoV receptor binding motifLakshminarasaiah Uppalapati, Anna Roitburd-Berman, Yael Weiss-Ottolenghi, et al.
NPJ Vaccines|October 26, 2022
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccinesSean A Nelson, Katherine A Richards, Maryah A Glover, et al.
Pageof 42

Showing results (101-110 of 420) with videos related to

Sort By:
Pageof 42
Journal of the International AIDS Society|December 29, 2017
Recent progress in immune-based interventions to prevent HIV-1 transmission to childrenYegor Voronin, Ilesh Jani, Barney S Graham, et al.
ACS Biomaterials Science & Engineering|January 26, 2018
Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell ResponsesBenjamin Schwarz, Kaitlyn M Morabito, Tracy J Ruckwardt, et al.
Plos Pathogens|March 5, 2016
A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited ImmunopathologyJie Liu, Elias K Haddad, Joshua Marceau, et al.
Msphere|April 26, 2019
Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus ProteinsRutger M Schepp, Cornelis A M de Haan, Deidre Wilkins, et al.
Plos One|February 12, 2020
Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidatesXueqiao Liu, Bo Liang, Xiang Liu, et al.
Nature Communications|March 18, 2023
Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F proteinPatrick O Byrne, Brian E Fisher, David R Ambrozak, et al.
Plos One|November 5, 2010
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)Laurence Peiperl, Cecilia Morgan, Zoe Moodie, et al.
Virology|June 5, 2019
A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virusYouri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Molecular Immunology|March 10, 2022
Functional reconstitution of the MERS CoV receptor binding motifLakshminarasaiah Uppalapati, Anna Roitburd-Berman, Yael Weiss-Ottolenghi, et al.
NPJ Vaccines|October 26, 2022
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccinesSean A Nelson, Katherine A Richards, Maryah A Glover, et al.
Pageof 42